Efektivitas Pemberian Vaksin terhadap Keterpaparan Covid-19 Tenaga Kesehatan di Kantor Kesehatan Pelabuhan Kelas I Soekarno Hatta

Budi Hendrawan, Yeny Sulistyowati, Sri Utami, Jontari Jontari

Abstract


Indonesia continues to launch vaccination programs to achieve herd immunity. For now, the Pfizer and Moderna vaccines complement the line of COVID-19 booster vaccines used by Indonesia. The government decided on the need to protect health workers as health workers who must be guaranteed their health in order to continue to provide health services to the community by issuing circulars and technical guidelines for the implementation of Bosster vaccinations for health workers, health worker assistants and other supporting personnel using the Moderna vaccine. This study was conducted to determine the effectiveness of vaccination with COVID-19 exposure of health workers at the Soekarno Hatta Health Office Class I Port. By using analytical observational research with a crossectional design. The sample in this study were 129 respondents. The research analysis used univariate, bivariate (paired sample t-test) and multivariate (logistic regression). Then it was found that there was a difference in the effectiveness of giving doses 1 and 2 of COVID-19 vaccination (Sinovac) with COVID-19 exposure. There is a difference in the effectiveness of giving doses of COVID-19 vaccination 1, 2 and dose 3 (Booster) with COVID-19 exposure and there is a significant difference between giving doses of COVID-19 vaccination 1 and 2 (Sinovac) and giving doses of COVID-19 vaccination 1, 2 and dose 3 (Booster) to the COVID-19 exposure of health workers at KKP Class I Soekarno-Hatta. And the most dominant factor is the administration of doses 1, 2 and 3 (Booster) vaccinations. Therefore, it is hoped that the Soekarno Hatta Class I KKP can provide Lab-based COVID-19 Serology Tests.

Keywords: Vaccination, booster and exposure to COVID-19

Keywords


Vaksinasi dosis 1 dan 2, vaksinasi dosis 1, 2 & 3 dan keterpaparan COVID-19

Full Text:

PDF

References


WHO. Coronavirus Disease (COVID19). 2020. Tersedia pada: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question- and-answers-hub/q-a-detail/coronavirus-disease-COVID-19#:~:text=symptoms (diakses, 13 April 2021).

Aco, H. Virus Corona. Ini rincian harga vaksin COVID-19 di Indonesia. 2020. Tersedia pada : https://www.tribunnews.com/nasional/2020/12/13/ini-rincian-harga- vak sin-COVID-19-di-indonesia?page=2(diakses 24Maret 2021).

APA. APA COVID-19 Information and Resources. 2021. Tersedia pada : https://www.apa.org/topics/COVID-19 (diakses 13 April 2021).

WHO. WHO remains firmly committed to the principles set out in the preamble to the Constitution. 2021. https://www.who.int/about/who-we- are/constitution (diakses, 13 April 2021)

Kemkes. 2021. Data Vaksinasi COVID-19 (Update per 28 Maret 2021, Tersedia pada: https://COVID19.go.id/p/berita/data-vaksinasi-COVID-19-update-28-maret- 2021.

Dinkes-Plg (Dinas Kesehatan Kota Palembang). 2021. Data Jumlah Tenaga Kesehatan yang Sudah Divaksinasi.

Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomized controlled trials in Brazil, South Africa, and the UK. The Lancet. 2021; 397(10269): 99-111.

Yvette. COVID: What do we know about China's coronavirus vaccines?. 2021. Tersedia pada : https://www.bbc.com/news/world-asia-china (diakses 24 Maret 2021).

Andrews., Stowe., Kirsebom., S. Toffa., et al. Covid-19 Vaccine Effectiveness Againts The Omicron (B.1.1.529) Variant. 2022. The New England Journal of Medicine. 2021;386:1532-1546. DOI: 10.1056/NEJMoa2119451

Fundrika, B.A. Bahan Vaksin COVID-19 Oxford Diisukan Terbuat dari Janin, Fakta atau Hoax?. 2020. Tersedia pada : https://www.suara.com/health(diakses 24 Maret 2021).

Fundrika, B.A. Vaksinasi COVID-19 di Indonesia Akan Dibagi Dua Gelombang, Begini Urutannya. 2021. Tersedia pada : https://www.suara.com/(diakses 24 Maret 2021).

Centre for Desease Control and Prevention (CDC). Information about the Pfizer-BioNTech COVID-19 Vaccine. 2021. General information. https:// www.cdc.gov /corona viru(diakses 24 Maret 2021).




DOI: https://doi.org/10.52643/jbik.v13i3.2564

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Jurnal Bidang Ilmu Kesehatan

Flag Counter

         

 

JURNAL BIDANG ILMU KESEHATAN by http://ejournal.urindo.ac.id/index.php/kesehatan is licensed under a Creative Commons Attribution 4.0 International License